111 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 28846301 | Zileuton | 2022 Jan | 2 |
2 | 34801853 | Paralog- and ortholog-specificity of inhibitors of human and mouse lipoxygenase-isoforms. | 2022 Jan | 1 |
3 | 35251467 | 5-Lipoxygenase Inhibition Protects Retinal Pigment Epithelium from Sodium Iodate-Induced Ferroptosis and Prevents Retinal Degeneration. | 2022 | 1 |
4 | 34116165 | Intrinsic 5-lipoxygenase activity regulates migration and adherence of mantle cell lymphoma cells. | 2021 Oct | 1 |
5 | 31785932 | Pharmaceutical analysis combined with in-silico therapeutic and toxicological profiling on zileuton and its impurities to assist in modern drug discovery. | 2020 Feb 5 | 2 |
6 | 31841698 | Zileuton use and phenotypic features in asthma. | 2020 Feb | 1 |
7 | 32795513 | High ability of zileuton ((±)-1-(1-benzo[b]thien-2-ylethyl)-1-hydroxyurea) to stimulate IK(Ca) but suppress IK(DR) and IK(M) independently of 5-lipoxygenase inhibition. | 2020 Nov 15 | 2 |
8 | 32799052 | A cheminformatic study on chemical space characterization and diversity analysis of 5-LOX inhibitors. | 2020 Nov | 2 |
9 | 31331653 | 5-Lipoxygenase as a drug target: A review on trends in inhibitors structural design, SAR and mechanism based approach. | 2019 Sep 1 | 1 |
10 | 29414995 | The peroxisome proliferator-activated receptor agonist pioglitazone and 5-lipoxygenase inhibitor zileuton have no effect on lung inflammation in healthy volunteers by positron emission tomography in a single-blind placebo-controlled cohort study. | 2018 | 1 |
11 | 29421656 | Inhibition of 5-lipoxygenase represses neutrophils activation and activates apoptosis in pancreatic tissues during acute necrotizing pancreatitis. | 2018 Mar 25 | 3 |
12 | 29953727 | Sinapic acid phenethyl ester as a potent selective 5-lipoxygenase inhibitor: Synthesis and structure-activity relationship. | 2018 Nov | 2 |
13 | 30199704 | Design, synthesis and identification of novel substituted 2-amino thiazole analogues as potential anti-inflammatory agents targeting 5-lipoxygenase. | 2018 Oct 5 | 1 |
14 | 30321850 | QSAR classification-based virtual screening followed by molecular docking studies for identification of potential inhibitors of 5-lipoxygenase. | 2018 Dec | 1 |
15 | 30410359 | Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway. | 2018 | 1 |
16 | 28680195 | New Hydroxycinnamic Acid Esters as Novel 5-Lipoxygenase Inhibitors That Affect Leukotriene Biosynthesis. | 2017 | 1 |
17 | 29290980 | Up-regulation of 5-lipoxygenase by inhibition of cathepsin G enhances TRAIL-induced apoptosis through down-regulation of survivin. | 2017 Dec 5 | 2 |
18 | 27599517 | 5-Lipoxygenase inhibitor zileuton inhibits Ca(2+)-responses induced by glutoxim and molixan in macrophages. | 2016 Jul | 3 |
19 | 24662827 | Increased metabolites of 5-lipoxygenase from hypoxic ovarian cancer cells promote tumor-associated macrophage infiltration. | 2015 Mar 5 | 1 |
20 | 25483364 | Inhibition of 5-lipoxygenase triggers apoptosis in pancreatic cancer cells. | 2015 Feb | 3 |
21 | 25597508 | Management of severe acne. | 2015 Jul | 1 |
22 | 26412995 | Hydroxyurea and Zileuton Differentially Modulate Cell Proliferation and Interleukin-2 Secretion by Murine Spleen Cells: Possible Implication on the Immune Function and Risk of Pain Crisis in Patients with Sickle Cell Disease. | 2015 Fall | 1 |
23 | 24525097 | High concentrations of genistein exhibit pro-oxidant effects in primary muscle cells through mechanisms involving 5-lipoxygenase-mediated production of reactive oxygen species. | 2014 May | 2 |
24 | 23505486 | Deoxyhypusine hydroxylase from Plasmodium vivax, the neglected human malaria parasite: molecular cloning, expression and specific inhibition by the 5-LOX inhibitor zileuton. | 2013 | 3 |
25 | 24026253 | Systems pharmacology models can be used to understand complex pharmacokinetic-pharmacodynamic behavior: an example using 5-lipoxygenase inhibitors. | 2013 Sep 11 | 1 |
26 | 24029553 | Quantification of the 5-lipoxygenase inhibitor zileuton in human plasma using high performance liquid chromatography-tandem mass spectrometry. | 2013 Oct 15 | 2 |
27 | 22680930 | Structure and ligand based drug design strategies in the development of novel 5- LOX inhibitors. | 2012 | 1 |
28 | 23245693 | The diversity of Stemona stilbenoids as a result of storage and fungal infection. | 2012 Dec 28 | 1 |
29 | 21299475 | Randomized trial of zileuton for treatment of COPD exacerbations requiring hospitalization. | 2011 Feb | 1 |
30 | 21833474 | 5-Lipoxygenase contributes to the progression of hepatocellular carcinoma. | 2011 Nov-Dec | 2 |
31 | 20880396 | The 5-lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages. | 2010 Oct | 4 |
32 | 19214143 | 5-lipoxygenase pharmacogenetics in asthma: overlap with Cys-leukotriene receptor antagonist loci. | 2009 Mar | 2 |
33 | 19280518 | 2-ABT-S-oxide detoxification by glutathione S-transferases A1-1, M1-1 and P1-1: implications for toxicity associated with zileuton. | 2009 Mar | 1 |
34 | 20436887 | Zileuton, a new efficient and safe systemic anti-acne drug. | 2009 May | 1 |
35 | 18927292 | Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model. | 2008 Oct 15 | 1 |
36 | 21437139 | Leukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: a systematic review. | 2008 Dec 9 | 1 |
37 | 17258303 | Assessment of in vivo 5-lipoxygenase activity by analysis of leukotriene B4 in saliva: effects of treatment with zileuton. | 2007 May | 1 |
38 | 17394438 | Zileuton: clinical implications of 5-Lipoxygenase inhibition in severe airway disease. | 2007 Apr | 2 |
39 | 17722971 | Clinical pattern of zileuton-associated liver injury: results of a 12-month study in patients with chronic asthma. | 2007 | 1 |
40 | 17982097 | FcepsilonRI- and Fcgamma receptor-mediated production of reactive oxygen species by mast cells is lipoxygenase- and cyclooxygenase-dependent and NADPH oxidase-independent. | 2007 Nov 15 | 1 |
41 | 16681569 | Is there a role for antileukotrienes in urticaria? | 2006 May | 1 |
42 | 15604543 | Zileuton, an oral 5-lipoxygenase inhibitor, directly reduces sebum production. | 2005 | 2 |
43 | 15705997 | The effects of a 5-lipoxygenase inhibitor on acute mountain sickness and urinary leukotriene e4 after ascent to high altitude. | 2005 Feb | 1 |
44 | 15475461 | Overexpression of 5-lipoxygenase in rat and human esophageal adenocarcinoma and inhibitory effects of zileuton and celecoxib on carcinogenesis. | 2004 Oct 1 | 1 |
45 | 15501964 | Modulation of pulmonary leukotriene B4 production by cyclooxygenase-2 inhibitors and lipopolysaccharide. | 2004 Oct 15 | 1 |
46 | 12735786 | Benefit-risk assessment of antileukotrienes in the management of asthma. | 2003 | 1 |
47 | 12756111 | A new concept for acne therapy: a pilot study with zileuton, an oral 5-lipoxygenase inhibitor. | 2003 May | 1 |
48 | 12923360 | The role of leukotriene inhibitors in patients with paranasal sinus disease. | 2003 Jun | 1 |
49 | 12949886 | Zileuton, a 5-lipoxygenase inhibitor, increases production of thromboxane A2 and platelet aggregation in patients with asthma. | 2003 Sep | 1 |
50 | 14570767 | Mechanism-based inhibition of human liver microsomal cytochrome P450 1A2 by zileuton, a 5-lipoxygenase inhibitor. | 2003 Nov | 2 |